BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12812315)

  • 1. A method for the detection of eosinophilic granulocytes in colonoscopic biopsies from IBD patients.
    Rubio CA
    Pathol Res Pract; 2003; 199(3):145-50. PubMed ID: 12812315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of the multigene analysis test in discriminating between ulcerative colitis and Crohn's disease: a retrospective study.
    Janczewska I; Kapraali M; Saboonchi F; Nekzada Q; Wessulv Å; Khoshkar J; Marouf F; Gorsetman J; Risberg D; Lissing M; Wirström G; Sandstedt B
    Scand J Gastroenterol; 2012 Feb; 47(2):162-9. PubMed ID: 22229803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
    Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
    Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
    Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
    Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation.
    Matsui T; Yao T; Sakurai T; Yao K; Hirai F; Matake H; Tsuda S; Wada Y; Iwashita A; Kamachi S
    J Gastroenterol; 2003; 38(7):647-55. PubMed ID: 12898357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role.
    Parente F; Cucino C; Bollani S; Imbesi V; Maconi G; Bonetto S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 2000 Mar; 95(3):705-11. PubMed ID: 10710061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between clinical data and histology of the large bowel in Crohn's disease and ulcerative colitis.
    Schmitz-Moormann P; Himmelmann GW; Brandes JW
    Pathol Annu; 1985; 20 Pt 1():281-301. PubMed ID: 3991239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C; Bateman A; Payne R; Johnson P; Sheron N
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease.
    Yantiss RK; Odze RD
    Am J Gastroenterol; 2007 Apr; 102(4):890-904. PubMed ID: 17324129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
    Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
    Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of CD30+ lymphocytes and eosinophils for the histopathological differential diagnosis of inflammatory bowel disease.
    Flores C; Francesconi CF; Meurer L
    J Crohns Colitis; 2015 Sep; 9(9):763-8. PubMed ID: 26048916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
    Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
    J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and colonoscopic characteristics of pediatric inflammatory bowel disease].
    Luo YY; Chen J
    Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):129-33. PubMed ID: 19573460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease.
    Lemberg DA; Clarkson CM; Bohane TD; Day AS
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1696-700. PubMed ID: 16246188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy.
    Joo M; Odze RD
    Am J Surg Pathol; 2010 May; 34(5):689-96. PubMed ID: 20410806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of serological markers of activated eosinophils in inflammatory bowel diseases.
    Dainese R; Galliani EA; De Lazzari F; D'Incà R; Mariné-Barjoan E; Vivinus-Nebot MH; Hébuterne X; Sturniolo GC; Piche T
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):393-7. PubMed ID: 22293328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
    Yantiss RK; Das KM; Farraye FA; Odze RD
    Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.